Back

Left atrial Soluble ST2 and BNP response after pulmonary vein isolation as a predictor of atrial fibrillation recurrence

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Arrhythmias and remodeling Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Mustafa Umut Somuncu

Adnan Menderes University, Aydin (Turkiye)

6 More presentations in this session

Presentation thumbnail
Remodeling and reverse-remodeling of left atrium and appendage after catheter ablation for atrial fibrillation
Doctor T. Kawaji (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Early reverse remodeling of the mitral valve apparatus following atrial fibrillation ablation: insights from a prospective echocardiographic study
Doctor S. Sanli (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Left-atrial function in relation to BMI in patients undergoing catheter ablation for atrial fibrillation
Mr C. Eitel (Kuenzell, DE)
Abstract Slides Video
Presentation thumbnail
P-wave signal-averaged ECG as a marker of left atrial electrical and structural remodeling in patients with atrial fibrillation
Doctor A. Karanikola (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Distinct atrial remodeling in valvular heart disease: insights from strain imaging and electrophysiological mapping
Ms M. Linderhof (Rotterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmias and remodeling

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Recurrence risk of atrial fibrillation in the 1-year post-ablation with radiofrequency in patients with high p wave dispersion and low voltage areas
thumbnail
Congress Session
Atrial fibrillation catheter ablation (1)
thumbnail
Congress Presentation
Biomarkers in atrial fibrillation: insights from the ACaSA study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources